Testmiljö
Observera att detta är en testmiljö för utveckling som inte ska användas som underlag för klinisk bedömning. Besök Janusmed här: https://janusmed.se

11/23/2024

Janusmed amning

Janusmed amning – Azathioprine

Janusmed amning tillhandahåller generella rekommendationer om huruvida ett friskt fullgånget spädbarn kan ammas när modern använder olika läkemedel. Observera att prematura och/eller sjuka spädbarn alltid kräver särskilda överväganden. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed amning och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Azatioprin Testmiljö

Azatioprin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Moretti ME, Verjee Z, Ito S, Koren G. Breast-feeding during maternal use of azathioprine. Ann Pharmacother 2006;40(12):2269-2272

  2. Sau A, Clarke S, Bass J, Kaiser A, Marinaki A, Nelson-Piercy C. Azathioprine and breastfeeding: is it safe? BJOG 2007;114(4):498-501

  3. Coulam CB, Moyer TP, Jiang NS, Zincke H. Breast-feeding after renal transplantation. Transplant Proc 1982;14(3):605-9.

  4. Christensen LA, Dahlerup JF, Schmiegelow K. Excretion of azathioprine metabolites in maternal milk. Gut 2005;54(Suppl VII):A45

  5. Christensen LA, Dahlerup JF, Nielsen MJ, Fallingborg JF, Schmiegelow K. Azathioprine treatment during lactation. Aliment Pharmacol Ther. 2008;28(10):1209-13.

  6. Kane SV, Present DH. Metabolites to immunomodulators are not detected in brest milk. Am J Gastroenterol 2004;99(10 Suppl):246-247

  7. Gardiner SJ, Gearry RB, Roberts RL, Zhang M, Barclay ML, Begg EJ. Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol 2006;62(4):453-6.

  8. Gardiner SJ, Gearry RB, Roberts RL, Zhang M, Barclay ML, Begg EJ. Comment: Breast-feeding during maternal use of azathioprine. Ann Pharmacother 2007;41(4):719-20.

  9. Bernard N, Garayt C, Chol F, Vial T, Descotes J. Prospective clinical and biological follow-up of three breastfed babies from azathioprine-treated mothers. Fundam Clin Pharmacol 2007;21(Suppl 1):62-3.

  10. Khare MM, Lott J, Currie A, Howarth E. Is it safe to continue azathioprine in breast feeding mothers? J Obstet Gynaecol 2003;23(Suppl 1):S48

  11. Grekas DM, Vasiliou SS, Lazarides AN. Immunosuppressive therapy and breast-feeding after renal transplantation. Nephron 1984;37(1):68

  12. Nyberg G, Haljamae U, Frisenette-Fich C, Wennergren M, Kjellmer I. Breast-feeding during treatment with cyclosporine. Transplantation 1998;65(2):253-255.

  13. Azathioprine. Lactmed (drugs and lactation database). Tillgänglig via: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT

  14. Angelberger S, Reinisch W, Messerschmidt A, Miehsler W, Novacek G, Vogelsang H et al. Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis. 2011;5:95-100.

  15. Zelinkova Z, De Boer IP, Van Dijke MJ, Kuipers EJ, Van Der Woude CJ. Azathioprine treatment during lactation. Aliment Pharmacol Ther. 2009;30:90-1; author reply 91.

  16. Munoz-Flores-Thiagarajan KD, Easterling T, Davis C, Bond EF. Breast-feeding by a cyclosporine-treated mother. Obstet Gynecol 2001;97(5 Pt 2):816-818.

  17. Werner M, Björnsson E, Prytz H, Lindgren S, Almer S, Broomé U et al. Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding?. Scand J Gastroenterol. 2007;42(8):986-91.

  18. de Meij TG, Jharap B, Kneepkens CM, van Bodegraven AA, de Boer NK, Dutch Initiative on Crohn and Colitis. Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(1):38-43.

  19. Bernard N, Gouraud A, Paret N, Cottin J, Descotes J, Vial T . Azathioprine and breastfeeding: long-term follow-up. Fundam Clin Pharmacol. 2013;27(Suppl 1:12):Abstract 05-03.

  20. Beswick L, Shukla D, Friedman A, Fazal M, Florin T, Andrews J, et al. National audit: Assessing the use and safety of allopurinol thiopurine co-therapy in pregnant females with inflammatory bowel disease. J Gastroenterol Hepatol. 2016;31(Suppl 2):128-129.

  1. Moretti ME, Verjee Z, Ito S, Koren G. Breast-feeding during maternal use of azathioprine. Ann Pharmacother 2006;40(12):2269-2272
  2. Sau A, Clarke S, Bass J, Kaiser A, Marinaki A, Nelson-Piercy C. Azathioprine and breastfeeding: is it safe? BJOG 2007;114(4):498-501
  3. Coulam CB, Moyer TP, Jiang NS, Zincke H. Breast-feeding after renal transplantation. Transplant Proc 1982;14(3):605-9.
  4. Christensen LA, Dahlerup JF, Schmiegelow K. Excretion of azathioprine metabolites in maternal milk. Gut 2005;54(Suppl VII):A45
  5. Christensen LA, Dahlerup JF, Nielsen MJ, Fallingborg JF, Schmiegelow K. Azathioprine treatment during lactation. Aliment Pharmacol Ther. 2008;28(10):1209-13.
  6. Kane SV, Present DH. Metabolites to immunomodulators are not detected in brest milk. Am J Gastroenterol 2004;99(10 Suppl):246-247
  7. Gardiner SJ, Gearry RB, Roberts RL, Zhang M, Barclay ML, Begg EJ. Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol 2006;62(4):453-6.
  8. Gardiner SJ, Gearry RB, Roberts RL, Zhang M, Barclay ML, Begg EJ. Comment: Breast-feeding during maternal use of azathioprine. Ann Pharmacother 2007;41(4):719-20.
  9. Bernard N, Garayt C, Chol F, Vial T, Descotes J. Prospective clinical and biological follow-up of three breastfed babies from azathioprine-treated mothers. Fundam Clin Pharmacol 2007;21(Suppl 1):62-3.
  10. Khare MM, Lott J, Currie A, Howarth E. Is it safe to continue azathioprine in breast feeding mothers? J Obstet Gynaecol 2003;23(Suppl 1):S48
  11. Grekas DM, Vasiliou SS, Lazarides AN. Immunosuppressive therapy and breast-feeding after renal transplantation. Nephron 1984;37(1):68
  12. Nyberg G, Haljamae U, Frisenette-Fich C, Wennergren M, Kjellmer I. Breast-feeding during treatment with cyclosporine. Transplantation 1998;65(2):253-255.
  13. Azathioprine. Lactmed (drugs and lactation database). Tillgänglig via: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT
  14. Angelberger S, Reinisch W, Messerschmidt A, Miehsler W, Novacek G, Vogelsang H et al. Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis. 2011;5:95-100.
  15. Zelinkova Z, De Boer IP, Van Dijke MJ, Kuipers EJ, Van Der Woude CJ. Azathioprine treatment during lactation. Aliment Pharmacol Ther. 2009;30:90-1; author reply 91.
  16. Munoz-Flores-Thiagarajan KD, Easterling T, Davis C, Bond EF. Breast-feeding by a cyclosporine-treated mother. Obstet Gynecol 2001;97(5 Pt 2):816-818.
  17. Werner M, Björnsson E, Prytz H, Lindgren S, Almer S, Broomé U et al. Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding?. Scand J Gastroenterol. 2007;42(8):986-91.
  18. de Meij TG, Jharap B, Kneepkens CM, van Bodegraven AA, de Boer NK, Dutch Initiative on Crohn and Colitis. Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(1):38-43.
  19. Bernard N, Gouraud A, Paret N, Cottin J, Descotes J, Vial T . Azathioprine and breastfeeding: long-term follow-up. Fundam Clin Pharmacol. 2013;27(Suppl 1:12):Abstract 05-03.
  20. Beswick L, Shukla D, Friedman A, Fazal M, Florin T, Andrews J, et al. National audit: Assessing the use and safety of allopurinol thiopurine co-therapy in pregnant females with inflammatory bowel disease. J Gastroenterol Hepatol. 2016;31(Suppl 2):128-129.

Innehållet senast uppdaterat 11/7/2024